BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4999877)

  • 1. Development of vaccines for coccidioidomycosis.
    Levine HB; Pappagianis D; Cobb JM
    Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
    Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
    PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
    [No Abstract]   [Full Text] [Related]  

  • 4. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
    Walch HA; Kalvoda A
    Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
    Levine HB; Scalarone GM
    Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
    [No Abstract]   [Full Text] [Related]  

  • 8. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
    Scalarone GM; Levine HB
    Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
    [No Abstract]   [Full Text] [Related]  

  • 9. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity in coccidioidomycosis.
    Cox RA; Magee DM
    Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
    [No Abstract]   [Full Text] [Related]  

  • 11. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
    Pappagianis D
    Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine against coccidioidomycosis is justified and attainable.
    Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
    Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against Coccidioides.
    Yoon HJ; Clemons KV
    Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
    Pappagianis D; Hector R; Levine HB; Collins MS
    Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherule coccidioidin in delayed dermal sensitivity reactions of experimental animals.
    Levine HB; Cobb JM; Scalarone GM
    Sabouraudia; 1969 Feb; 7(1):20-32. PubMed ID: 5375339
    [No Abstract]   [Full Text] [Related]  

  • 18. The Rise of
    Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
    Front Immunol; 2019; 10():2188. PubMed ID: 31572393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
    Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
    Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.